$ABEO
ABEONA THERAPEUTICS INC.

2019 Q2 Form 10-Q Financial Statement

#000114420419025271 Filed on May 10, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $0.00 $480.0K
YoY Change -100.0% 118.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.610M $5.660M $7.630M
YoY Change 21.17% 96.53% 145.34%
% of Gross Profit
Research & Development $16.31M $11.74M $9.470M
YoY Change 106.04% 43.8% 65.97%
% of Gross Profit
Depreciation & Amortization $2.060M $1.658M $1.390M
YoY Change 610.34% 852.87% 892.86%
% of Gross Profit
Operating Expenses $23.98M $11.74M $9.470M
YoY Change 202.93% 43.8% 65.97%
Operating Profit -$19.05M -$18.01M
YoY Change 78.36% 105.83%
Interest Expense $500.0K $530.0K
YoY Change 233.33% 76.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$23.92M -$18.56M -$17.48M
YoY Change 95.42% 76.26% 106.86%
Income Tax
% Of Pretax Income
Net Earnings -$23.92M -$18.56M -$17.48M
YoY Change 95.38% 76.21% 106.85%
Net Earnings / Revenue -3641.46%
Basic Earnings Per Share
Diluted Earnings Per Share -$488.6K -$387.1K -$360.6K
COMMON SHARES
Basic Shares Outstanding 49.16M 47.95M 47.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.50M $68.30M $85.00M
YoY Change -47.83% -48.26% -38.32%
Cash & Equivalents $42.60M $25.92M $18.75M
Short-Term Investments $19.90M $42.40M $66.20M
Other Short-Term Assets $2.300M $3.400M $3.800M
YoY Change 21.05% 61.9% 40.74%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $64.90M $71.72M $88.85M
YoY Change -46.73% -46.54% -36.8%
LONG-TERM ASSETS
Property, Plant & Equipment $22.10M $10.36M $9.443M
YoY Change 176.01% 116.25% 587.26%
Goodwill $32.47M $32.47M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $1.100M $600.0K
YoY Change 83.33% 175.0% 50.0%
Total Long-Term Assets $94.50M $94.42M $85.55M
YoY Change 110.6% 127.5% 124.1%
TOTAL ASSETS
Total Short-Term Assets $64.90M $71.72M $88.85M
Total Long-Term Assets $94.50M $94.42M $85.55M
Total Assets $159.4M $166.1M $174.4M
YoY Change -4.38% -5.42% -2.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.200M $4.189M $6.122M
YoY Change 24.5% -29.12% 225.47%
Accrued Expenses $8.100M $5.241M $3.936M
YoY Change 668.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.50M $21.42M $20.35M
YoY Change 340.95% 794.94% 263.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $26.70M $26.90M $20.00M
YoY Change 545.16%
Total Long-Term Liabilities $26.70M $26.90M $20.00M
YoY Change 545.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.50M $21.42M $20.35M
Total Long-Term Liabilities $26.70M $26.90M $20.00M
Total Liabilities $52.30M $48.34M $40.35M
YoY Change 804.37% 1920.18% 365.55%
SHAREHOLDERS EQUITY
Retained Earnings -$428.7M -$410.2M
YoY Change 21.28% 14.01%
Common Stock $546.5M $544.2M
YoY Change 2.39% 2.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $107.2M $117.8M $134.0M
YoY Change
Total Liabilities & Shareholders Equity $159.4M $166.1M $174.4M
YoY Change -4.38% -5.42% -2.44%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$23.92M -$18.56M -$17.48M
YoY Change 95.38% 76.21% 106.85%
Depreciation, Depletion And Amortization $2.060M $1.658M $1.390M
YoY Change 610.34% 852.87% 892.86%
Cash From Operating Activities -$15.24M -$15.08M -$16.97M
YoY Change 68.96% 269.38% 236.04%
INVESTING ACTIVITIES
Capital Expenditures -$4.220M $1.226M -$10.91M
YoY Change 23.39% -64.99% 1458.57%
Acquisitions
YoY Change
Other Investing Activities $23.14M $24.00M $13.04M
YoY Change -133.13%
Cash From Investing Activities $18.92M $22.77M $2.120M
YoY Change -125.82% -750.31% -402.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.01M 28.00K 0.000
YoY Change 2182.46% -98.47% -100.0%
NET CHANGE
Cash From Operating Activities -15.24M -15.08M -16.97M
Cash From Investing Activities 18.92M 22.77M 2.120M
Cash From Financing Activities 13.01M 28.00K 0.000
Net Change In Cash 16.69M 7.724M -14.85M
YoY Change -120.42% -234.21% -118.22%
FREE CASH FLOW
Cash From Operating Activities -$15.24M -$15.08M -$16.97M
Capital Expenditures -$4.220M $1.226M -$10.91M
Free Cash Flow -$11.02M -$16.30M -$6.060M
YoY Change 96.79% 114.98% 39.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25924000
CY2019Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
38000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
81000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3372000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3802000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
71721000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
88851000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18750000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10356000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9443000
CY2019Q1 us-gaap Goodwill
Goodwill
32466000
CY2018Q4 us-gaap Goodwill
Goodwill
32466000
CY2019Q1 abeo Other Assetsand Restricted Cash
OtherAssetsandRestrictedCash
1147000
CY2018Q4 abeo Other Assetsand Restricted Cash
OtherAssetsandRestrictedCash
597000
CY2019Q1 us-gaap Assets
Assets
166136000
CY2018Q4 us-gaap Assets
Assets
174399000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4189000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6122000
CY2019Q1 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
10000000
CY2018Q4 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
10000000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21416000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20354000
CY2019Q1 us-gaap Liabilities
Liabilities
48343000
CY2018Q4 us-gaap Liabilities
Liabilities
40354000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
479000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
479000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
546057000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
543754000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-428743000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410188000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
117793000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
134045000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
166136000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174399000
CY2019Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
44859000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
44859000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3162000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1817000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
41697000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43042000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4033000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5378000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5378000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5378000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5378000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
16152000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
41697000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1345000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
42387000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
66218000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11737000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8162000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5659000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2878000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1658000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
19054000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
11214000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19054000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10683000
CY2019Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
499000
CY2018Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
156000
CY2019Q1 abeo Interest And Other Expense
InterestAndOtherExpense
0
CY2018Q1 abeo Interest And Other Expense
InterestAndOtherExpense
3000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-18555000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-10530000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47948421
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47060523
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-18555000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-10530000
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-43000
CY2018Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-43000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15078000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4082000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1226000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3502000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
22774000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3502000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-430000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-643000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1829000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
28000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1685000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2103000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000
CY2019Q1 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
172000
CY2018Q1 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
172000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5241000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3936000
CY2019Q1 abeo Payable Due Licensor Non Current
PayableDueLicensorNonCurrent
20000000
CY2018Q4 abeo Payable Due Licensor Non Current
PayableDueLicensorNonCurrent
20000000
CY2019Q1 us-gaap Revenues
Revenues
0
CY2018Q1 us-gaap Revenues
Revenues
531000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24000000
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2019Q1 us-gaap Other Noncash Income
OtherNoncashIncome
169000
CY2018Q1 us-gaap Other Noncash Income
OtherNoncashIncome
0
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7724000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5755000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19310000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138030000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27034000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132275000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25924000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131995000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1110000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
280000
CY2019Q1 abeo Cash And Cash Equivalents Restricted Cash
CashAndCashEquivalentsRestrictedCash
27034000
CY2018Q1 abeo Cash And Cash Equivalents Restricted Cash
CashAndCashEquivalentsRestrictedCash
132275000
CY2019Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
68300000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
134045000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2103000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
172000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
28000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-18555000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
170098000
CY2018Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
6275000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
172000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1685000
CY2018Q1 abeo Non Cash Or Part Non Cash Acquisition Non Cash Financial Or Equity Instrument Consideration Value Of Warrants Issued1
NonCashOrPartNonCashAcquisitionNonCashFinancialOrEquityInstrumentConsiderationValueOfWarrantsIssued1
0
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-10530000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
169744000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47949694
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47944486
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47949694
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47944486
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0246
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0237
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
42387000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66218000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0
CY2019Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
296000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
296000
CY2019Q1 abeo Increase Decrease Right Of Use Assets And Other Assets
IncreaseDecreaseRightOfUseAssetsAndOtherAssets
150000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8900000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
289000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
73000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
47000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1266000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1699000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1713000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1727000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1741000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3667000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11813000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3196000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8617000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P82M
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1690000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6927000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2019Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
8749000
CY2018Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2019Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6927000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1690000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0
CY2018Q1 abeo Increase Decrease Right Of Use Assets And Other Assets
IncreaseDecreaseRightOfUseAssetsAndOtherAssets
0
CY2019Q1 abeo Increase Decrease In Accounts Payable And Accrued And Lease Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndLeaseLiabilities
910000
CY2018Q1 abeo Increase Decrease In Accounts Payable And Accrued And Lease Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndLeaseLiabilities
-3516000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.29
CY2019Q1 abeo Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExercisePrice
6.69
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.83
CY2018Q1 abeo Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExercisePrice
13.72
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Results
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingResults
2067000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
2067000
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Results
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingResults
543000
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
543000
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.01
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.04
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
ABEONA THERAPEUTICS INC.
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000318306
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
ABEO
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49162047
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q1 abeo Stock Issued During Period Valuewarrants Exercised
StockIssuedDuringPeriodValuewarrantsExercised
144000

Files In Submission

Name View Source Status
0001144204-19-025271-index-headers.html Edgar Link pending
0001144204-19-025271-index.html Edgar Link pending
0001144204-19-025271.txt Edgar Link pending
0001144204-19-025271-xbrl.zip Edgar Link pending
abeo-20190331.xml Edgar Link completed
abeo-20190331.xsd Edgar Link pending
abeo-20190331_cal.xml Edgar Link unprocessable
abeo-20190331_def.xml Edgar Link unprocessable
abeo-20190331_lab.xml Edgar Link unprocessable
abeo-20190331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv520699_10q.htm Edgar Link pending
tv520699_ex3-1.htm Edgar Link pending
tv520699_ex31-1.htm Edgar Link pending
tv520699_ex31-2.htm Edgar Link pending
tv520699_ex32.htm Edgar Link pending
tv520699_img1.jpg Edgar Link pending